Cross Country Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cross Country Healthcare generated cash of $248,498,000, which is more than the previous year. Cash used in financing activities reached the amount of -$221,241,000 last year. Net change in cash is therefore $13,490,000.
Cash Flow
| 2014 | -4.07M | -45.45M | 46.45M |
|---|---|---|---|
| 2015 | 18.23M | -24.07M | 3.35M |
| 2016 | 30.14M | -9.78M | -2.16M |
| 2017 | 45.50M | -91.38M | 50.75M |
| 2018 | 20.99M | -6.67M | -23.76M |
| 2019 | 5.54M | -2.94M | -17.59M |
| 2020 | 27.20M | -4.61M | -22.01M |
| 2021 | -85.61M | -34.04M | 119.09M |
| 2022 | 134.05M | -43.87M | -87.59M |
| 2023 | 248.49M | -13.77M | -221.24M |
CCRN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.60M | 1.03M | 1.6M | 1.03M | 16.01M | 25.53M | 20.63M | 2.45M | 4.99M | 8.05M |
Operating activities | ||||||||||
Net income | 72.63M | 188.46M | 132.00M | -12.14M | -55.94M | -15.71M | 38.80M | 8.73M | 4.95M | -31.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 18.34M | 12.57M | 9.85M | 12.67M | 14.07M | 11.78M | 10.17M | 9.18M | 8.06M | 7.44M |
Stock-based compensation expense | 6.57M | 7.39M | 6.89M | 5.40M | 3.39M | 0 | 4.08M | 3.37M | 2.46M | 1.38M |
| Deferred income tax benefit | 6.57M | 7.39M | 6.89M | 5.40M | 3.39M | 0 | 4.08M | 3.37M | 2.46M | 1.38M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 251.42M | -153.22M | -318.42M | -4.74M | -6.64M | 2.82M | 9.70M | -30.78M | -28.70M | -16.11M |
Inventories | 0 | 0 | -83.28M | -7.23M | 1.30M | 7.09M | 1.81M | -1.52M | 3.54M | 1.03M |
Accounts payable | -126.61M | 79.71M | 83.28M | 7.23M | -1.30M | -7.09M | -9.27M | 20.37M | 11.21M | 5.65M |
Cash generated by operating activities | 248.49M | 134.05M | -85.61M | 27.20M | 5.54M | 20.99M | 45.50M | 30.14M | 18.23M | -4.07M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -13.97M | -8.78M | -7.17M | -4.61M | -2.94M | -4.59M | -5.11M | -6.52M | -2.36M | -4.57M |
Acquisitions Net | 199K | -35.08M | -26.87M | -1.15M | -1.57M | -2.08M | -86.26M | -3.25M | -21.70M | 3.75M |
Cash generated by investing activities | -13.77M | -43.87M | -34.04M | -4.61M | -2.94M | -6.67M | -91.38M | -9.78M | -24.07M | -45.45M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -57.65M | -35.28M | -2.23M | -658K | -801K | -5M | -1.77M | 0 | -543K | -245K |
Repayments of term debt | -150.67M | -38.50M | -490.86M | -440.32M | -14.96M | -16.12M | 55.5M | -98.37M | 4.5M | 47.91M |
Cash used in financing activities | -221.24M | -87.59M | 119.09M | -22.01M | -17.59M | -23.76M | 50.75M | -2.16M | 3.35M | 46.45M |
Net Change In Cash | 13.49M | 2.56M | -564K | 568K | -14.98M | -9.51M | 4.90M | 18.17M | -2.54M | -3.06M |
Cash at end of period | 17.09M | 3.60M | 1.03M | 1.6M | 1.03M | 16.01M | 25.53M | 20.63M | 2.45M | 4.99M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |